Standout Papers

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Rando... 2010 2026 2015 2020 636
  1. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program (2010)
    David W. Dodick, Catherine C. Turkel et al. Headache The Journal of Head and Face Pain

Immediate Impact

80 standout
Sub-graph 1 of 20

Citing Papers

A Monoclonal Antibody to PACAP for Migraine Prevention
2024 Standout
Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes
2024 Standout
2 intermediate papers

Works of Ronald E. DeGryse being referenced

Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example
2014
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
2013

Author Peers

Author Last Decade Papers Cites
Ronald E. DeGryse 1935 1212 1332 44 2.5k
Enrico Marano 3084 1201 1904 34 3.7k
Roberto De Simone 3361 1236 2033 71 4.3k
HC Diener 2232 1150 1382 65 3.5k
F Sorge 2861 1112 1685 27 3.2k
P Carrieri 2920 1208 1966 56 4.6k
Neil H. Raskin 1234 679 925 51 2.4k
Ottar Sjaastad 2250 1248 1916 158 3.6k
Christian Lampl 2297 816 1333 67 2.9k
Seymour Solomon 2071 869 1373 99 2.6k
Marek Gawel 1471 760 870 75 2.7k

All Works

Loading papers...

Rankless by CCL
2026